Kneat Partners with Global Pharma to Transform Validation Processes
Kneat Secures Major Contract with Global Pharma
Kneat.com, Inc. (NASDAQ: KSI, OTC: KSIOF), known for its digital transformation in validation and quality assurance, has successfully signed a significant three-year Master Services Agreement with a leading global pharmaceutical company. This collaboration is a substantial milestone in Kneat's mission to digitize and streamline complex validation processes.
The Pharma Company's Background
The pharmaceutical company in question is a renowned manufacturer with a robust presence in over 120 countries. With a workforce exceeding 11,000 employees across multiple facilities, it specializes in consumer healthcare products and various pharmaceuticals. This company opted for Kneat’s solutions after an extensive evaluation process, underscoring Kneat's reputation and the effectiveness of its digital platform.
Driving Efficiency with Digital Solutions
The driving force behind this agreement is to enhance the efficiency, accuracy, and compliance of the pharma company's validation processes. This initiative will kick off with Computer System Validation (CSV), which is critical for the company's operational integrity and regulatory adherence. Eddie Ryan, CEO of Kneat, emphasized the significance of this partnership, stating, "This announcement further demonstrates Kneat's leadership position across the full Validation spectrum. We look forward to supporting this company to achieve harmonization for all their validation processes on a single platform."
Why Choose Kneat Gx?
Kneat's digital validation platform, Kneat Gx, is specifically designed for highly regulated industries, offering remarkable efficiency in validation and compliance. It boasts a user-friendly interface, expert customer support, and comprehensive training resources. Kneat Gx’s capabilities enable organizations to manage all aspects of validation from start to finish, ensuring stringent compliance with standards such as ISO 9001, ISO 27001, and 21 CFR Part 11/Annex 11. This robust certification ensures that not only is the platform effective, but it is also reliable under rigorous audit conditions.
Measurable Benefits Experienced by Customers
Multiple independent studies have highlighted significant improvements among Kneat’s clients. Companies utilizing Kneat Gx report a remarkable 40% reduction in validation cycle times. Furthermore, these organizations have witnessed a nearly 20% increase in speed to market and an 80% decrease in changeover time, leading to optimized workflows and enhanced productivity across the board.
Investing in the Future of Validation
Kneat’s commitment to innovation continues to shape the future of validation processes. By partnering with a major player in the pharmaceutical industry, Kneat will not only cement its position as a leader in compliance but also set new standards for what can be achieved through effective digital transformation. As organizations increasingly recognize the need for efficient validation processes, Kneat is well-positioned to provide the necessary tools to meet these demands.
Contact Information for Further Inquiries
For additional information relating to this announcement, Katie Keita from Kneat Investor Relations is available for inquiries. She can be reached at +1 902-450-2660 or via email at investors@kneat.com.
Frequently Asked Questions
What is the significance of the agreement with the global pharma company?
This agreement enables Kneat to digitize the pharma company's validation processes, enhancing efficiency and compliance across its operations.
How does Kneat Gx improve validation processes?
Kneat Gx streamlines validation workflows, reduces cycle times by 40%, and enhances speed to market, thereby offering substantial operational advantages.
What industries benefit from Kneat's services?
Kneat primarily serves highly regulated industries including pharmaceuticals, biotechnology, and other sectors requiring stringent compliance standards.
What certifications does Kneat Gx hold?
Kneat Gx is certified under ISO 9001, ISO 27001, and compliant with 21 CFR Part 11/Annex 11, ensuring high standards in validation.
Who can I contact for more information about Kneat?
For more information, you can reach out to Katie Keita from Kneat Investor Relations at +1 902-450-2660 or at investors@kneat.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.